Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/2376
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOlawumi, H.O-
dc.contributor.authorOlatunji, P.O-
dc.date.accessioned2024-07-24T10:14:54Z-
dc.date.available2024-07-24T10:14:54Z-
dc.date.issued2001-
dc.identifier.citationAfr. J. Med. med. Sci. (2001) 30, 319-321en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/2376-
dc.descriptionArticleen_US
dc.description.abstractSera from 250 selected group lO' donors were screened for anti A and anti B haemolysins. Those that were positive were titrated for haemolytic antibodies and the result read both visually and spcctrophotometrically. The visual and spectrophotometry titres were then compared. The prevalence of (X and P hacmolysin was 23.2%. Haemolytic anti B occurred twice as frequent as haemolytic anti A but the titre of haemolytic anti-A was higher than haemolytic anti-B. There was no relationship between sex and age and the prevalence of haemolysins. Significant v isual titre of 8 and above was found in 18.5% of lytic antiA and 13.2% of lytic anti-B, but the proportion of the whole study population with significant visual titre of 8 and above was low, i.e., 2.0% for anti-A and 2.8% for anti-B. On the average the spectrophotometric titres were consistently one fold higher than the visual titreen_US
dc.description.sponsorshipCollege of medicineen_US
dc.language.isoenen_US
dc.publisherCOLLEGE OF MEDICINEen_US
dc.subjectGroup O ' donorsen_US
dc.subjectprevalenceen_US
dc.subjecthaemolysinen_US
dc.subjectantibodiesen_US
dc.titlePrevalence and titre of alpha and beta haemolysins in blood group cO' donors in Ilorinen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Olawumi & Olatunji_Prevelence_2001.pdfArticle8.64 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.